Nanochemistry plays a pivotal role in the pharmaceutical field, revolutionizing drug delivery and therapeutic strategies. At the nanoscale, materials exhibit unique properties that can be harnessed to enhance drug efficacy, bioavailability, and targeted delivery. Nanoparticles, liposomes, and nanocarriers are among the key innovations in nanochemistry that have gained prominence in pharmaceutical research. These nanoscale systems offer advantages such as increased drug solubility, prolonged circulation time, and specific targeting to diseased tissues. In drug formulation, nanochemistry allows for the precise control of particle size and surface characteristics, influencing the pharmacokinetics and pharmacodynamics of therapeutic agents.
Moreover, nanomaterials enable the co-delivery of multiple drugs, addressing the complexities of combination therapy. The development of nanoscale drug delivery systems has also contributed to minimizing side effects and improving patient compliance. As nanochemistry continues to advance, it holds the promise of optimizing pharmaceutical formulations, enabling the design of personalized medicine, and unlocking new frontiers in the treatment of various diseases. The integration of nanochemistry in the pharmaceutical field represents a transformative approach, fostering innovation and propelling the industry towards more effective and targeted therapeutic solutions.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand